𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A prospective study of different types of hormone replacement therapy use and the risk of subsequent breast cancer: the women's health in the Lund area (WHILA) study (Sweden)

✍ Scribed by Helena Jernström; Pär-Ola Bendahl; Jonas Lidfeldt; Christina Nerbrand; Carl-David Agardh; Göran Samsioe

Book ID
111552276
Publisher
Springer Netherlands
Year
2003
Tongue
English
Weight
104 KB
Volume
14
Category
Article
ISSN
0957-5243

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Breast cancer risk in relation to differ
Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort
✍ Agnès Fournier; Franco Berrino; Elio Riboli; Valérie Avenel; Françoise Clavel-Ch 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 96 KB 👁 2 views

## Abstract Most epidemiological studies have shown an increase in breast cancer risk related to hormone replacement therapy (HRT) use. A recent large cohort study showed effects of similar magnitude for different types of progestogens and for different routes of administration of estrogens evaluat

Hormone replacement therapy and the risk
Hormone replacement therapy and the risk of breast cancer. Nested case-control study in a cohort of Swedish women attending mammography screening
✍ Ingemar Persson; Erik Thurfjell; Reinhold Bergström; Lars Holmberg 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 37 KB 👁 3 views

There is concern that hormone replacement therapy (HRT) increases the risk of breast cancer. We undertook a casecontrol study of this risk relationship within a cohort of 40-to 74-year-old women in Uppsala County, Sweden, who participated in mammography screening. Incident cases of breast cancer wer

Hormone replacement therapy and breast c
Hormone replacement therapy and breast cancer in former users of oral contraceptives—The Norwegian Women and Cancer study
✍ Eiliv Lund; Kjersti Bakken; Vanessa Dumeaux; Vegard Andersen; Merethe Kumle 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 66 KB 👁 2 views

## Abstract Combined estrogen–progestin menopausal therapy (HRT) and combined estrogen–progestin contraceptives (OC) both increase breast cancer risk during current use and a few years after. We investigated risk of breast cancer in women who were users of HRT dependant on former history of OC use